Moderna’s mRNA dreams meet reality with first post-Covid shot
The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna’s first chance to show the versatility of mRNA technology to more effectively treat and prevent a range of illnesses from the flu to cancer.
The post Moderna’s mRNA dreams meet reality with first post-Covid shot appeared first on Boston.com…
Read More